Global Digital Pathology Market - Premium Insight, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q1 2018 Update)
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Instruments
- 2.1.1.1. Secondary Instrument
- 2.1.1.2. Primary Instrument
- 2.1.2. Research Approaches
- 2.1.2.1. Bottom-up Approach
- 2.1.2.2. Top-down Approach
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.1.5. Vendor Inclusion Criteria
- 2.1.1. Research Instruments
- 2.2. Forecasting Methodology
- 2.2.1. Methodology for Market Estimation & Forecasting
- 2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Data Feed
- 4.3. Market Vendor Ranking Analysis
- 4.4. Market Dynamics
- 4.4.1. Drivers
- 4.4.1.1. Quality improvement in service delivery
- 4.4.1.2. Increasing prevalence of chronic disease
- 4.4.1.3. Technological advancement in healthcare
- 4.4.2. Restraints
- 4.4.2.1. High cost system and lack of standards
- 4.4.3. Opportunities
- 4.4.3.1. Streamline drug development processes in discovery, pre-clinical and clinical trials
- 4.4.3.2. Evolving technologies improve the pathologist’s workstation experience
- 4.4.3.3. Increasing use in education, research, and training
- 4.4.4. Challenges
- 4.4.4.1. Legal barriers and cultural resistance
- 4.4.4.2. Data management and storage challenges
5. Global Digital Pathology Market, by End User
- 5.1. Introduction
- 5.2. Academic & Research Institutes
- 5.3. Infectious Diseases
- 5.4. Laboratories
- 5.5. Pharmaceutical & Biotechnology Companies
6. Global Digital Pathology Market, by Deployment
- 6.1. Introduction
- 6.2. On-Cloud
- 6.3. On-Premises
7. Global Digital Pathology Market, by Geography
- 7.1. Introduction
- 7.2. Americas Digital Pathology Market
- 7.2.1. Americas Digital Pathology Market, by Country
- 7.2.1.1. United States
- 7.2.1.2. Brazil
- 7.2.1.3. Canada
- 7.2.1.4. Mexico
- 7.2.1.5. Argentina
- 7.2.2. Americas Digital Pathology Market, by End User
- 7.2.3. Americas Digital Pathology Market, by Deployment
- 7.2.1. Americas Digital Pathology Market, by Country
- 7.3. Europe, Middle East & Africa Digital Pathology Market
- 7.3.1. Europe, Middle East & Africa Digital Pathology Market, by Country
- 7.3.1.1. United Kingdom
- 7.3.1.2. Germany
- 7.3.1.3. France
- 7.3.1.4. Saudi Arabia
- 7.3.1.5. United Arab Emirates
- 7.3.1.6. Italy
- 7.3.1.7. Russia
- 7.3.2. Europe, Middle East & Africa Digital Pathology Market, by End User
- 7.3.3. Europe, Middle East & Africa Digital Pathology Market, by Deployment
- 7.3.1. Europe, Middle East & Africa Digital Pathology Market, by Country
- 7.4. Asia-Pacific Digital Pathology Market
- 7.4.1. Asia-Pacific Digital Pathology Market, by Country
- 7.4.1.1. China
- 7.4.1.2. Japan
- 7.4.1.3. India
- 7.4.1.4. Australia
- 7.4.2. Asia-Pacific Digital Pathology Market, by End User
- 7.4.3. Asia-Pacific Digital Pathology Market, by Deployment
- 7.4.1. Asia-Pacific Digital Pathology Market, by Country
8. Competitive Strategic Window
- 8.1. Introduction
- 8.1.1. Leverage Zone
- 8.1.2. Vantage Zone
- 8.1.3. Speculative Zone
- 8.1.4. Bottleneck Zone
9. FPNV Positioning Matrix
- 9.1. Introduction
- 9.2. Scores
- 9.2.1. Forefront
- 9.2.2. Pathfinders
- 9.2.3. Niche
- 9.2.4. Vital
- 9.3. Business Strategy
- 9.4. Product Satisfaction
10. Competitive News Feed Analysis
11. Company Usability Profiles
- 11.1. 3DHISTECH Ltd
- 11.2. Corista LLC
- 11.3. DeepBio, Inc.
- 11.4. Definiens, Inc.
- 11.5. Hamamatsu Photonics K.K.
- 11.6. Huron Digital Pathology
- 11.7. Indica Labs
- 11.8. Inspirata, Inc.
- 11.9. Leica Biosystems Nussloch Gmbh
- 11.10. OptraSCAN, Inc.
- 11.11. Philips Healthcare
- 11.12. Proscia, Inc.
- 11.13. Sectra AB
- 11.14. Ventana Medical Systems, Inc.
- 11.15. Visiopharm
12. Appendix
- 12.1. Top Reports
- 12.2. Author Details
LIST OF TABLES (26 TABLES)
TABLE 1. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2015 - 2024 (USD MILLION)
TABLE 2. GLOBAL DIGITAL PATHOLOGY MARKET RANKING, BY VENDORS, 2016
TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2015 - 2024 (USD MILLION)
TABLE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)
TABLE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)
TABLE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)
TABLE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)
TABLE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT, 2015 - 2024 (USD MILLION)
TABLE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ON-CLOUD, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)
TABLE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ON-PREMISES, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)
TABLE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GEOGRAPHY, 2015 - 2024 (USD MILLION)
TABLE 12. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, 2015 - 2024 (USD MILLION)
TABLE 13. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2015 - 2024 (USD MILLION)
TABLE 14. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT, 2015 - 2024 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, 2015 - 2024 (USD MILLION)
TABLE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2015 - 2024 (USD MILLION)
TABLE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT, 2015 - 2024 (USD MILLION)
TABLE 18. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, 2015 - 2024 (USD MILLION)
TABLE 19. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2015 - 2024 (USD MILLION)
TABLE 20. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT, 2015 - 2024 (USD MILLION)
TABLE 21. 360IRESEARCH SCORES FOR FOREFRONT IN DIGITAL PATHOLOGY MARKET
TABLE 22. 360IRESEARCH SCORES FOR PATHFINDERS IN DIGITAL PATHOLOGY MARKET
TABLE 23. 360IRESEARCH SCORES FOR NICHE IN DIGITAL PATHOLOGY MARKET
TABLE 24. 360IRESEARCH SCORES FOR VITAL IN DIGITAL PATHOLOGY MARKET
TABLE 25. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR DIGITAL PATHOLOGY MARKET
TABLE 26. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR DIGITAL PATHOLOGY MARKET
LIST OF FIGURES (24 TABLES)
FIGURE 1. GLOBAL DIGITAL PATHOLOGY MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIGITAL PATHOLOGY MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. DIGITAL PATHOLOGY MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2015 - 2024 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2016 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2016 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORIES, BY GEOGRAPHY, 2016 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2016 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT, 2016 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ON-CLOUD, BY GEOGRAPHY, 2016 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ON-PREMISES, BY GEOGRAPHY, 2016 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GEOGRAPHY, 2016 (USD MILLION)
FIGURE 21. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2024
FIGURE 22. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL PATHOLOGY MARKET, BY DEPLOYMENT, 2024
FIGURE 23. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY, 2024
FIGURE 24. 360IRESEARCH FPNV POSITIONING MATRIX FOR DIGITAL PATHOLOGY MARKET
- 4.4.1. Drivers
The global digital pathology market is expected to grow from USD 360.53 million 2016 to USD 980.65 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 13.32%.
“Quality improvement in service deliveryis one of the factors largely attributing to the growth of digital pathology market globally”
The factors attributing to the growth of the market are quality improvement in service delivery, increasing prevalence of chronic disease, and technological advancement in healthcare. However, some factors such as and high cost system and lack of standards may hinder the market growth. The global digital pathology market is expected to showcase the opportunities such as streamline drug development processes in discovery, pre-clinical and clinical trials, evolving technologies improve the pathologist’s workstation experience, and increasing use in education, research, and training. In the near future, the market may face the possible challenges in the growth due to legal barriers and cultural resistance, and data management and storage challenges. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global digital pathology market market.“Pharmaceutical & Biotechnology Companies: The highest growing end user for the global digital pathology market”
On the basis of end user, the global digital pathology market is studied across Academic & Research Institutes, Infectious Diseases, Laboratories, and Pharmaceutical & Biotechnology Companies. Among all these end user, the Pharmaceutical & Biotechnology Companies has captured the maximum market share while the Infectious Diseases has the opportunity to emerge with the highest CAGR.“On-Premises: The highest growing deployment for the global digital pathology market”
On the basis of deployment, the global digital pathology market is studied across On-Cloud and On-Premises. Among all these deployment, the On-Premises has captured the maximum market share while the On-Cloud has the opportunity to emerge with the highest CAGR.“Americas: The highest growing geography for the global digital pathology market”
On the basis of geography, the global digital pathology market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia). Among all these geography, the Asia-Pacific is showing the maximum growth in the near future with the highest CAGR while the Americas is dominating the market with highest market size.
“3DHISTECH Ltd: The potential growing player for the global digital pathology market”
The key players profiled in the global digital pathology market are 3DHISTECH Ltd, Corista LLC, DeepBio, Inc., Definiens, Inc., Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Inspirata, Inc., Leica Biosystems Nussloch Gmbh, OptraSCAN, Inc., Philips Healthcare, Proscia, Inc., Sectra AB, Ventana Medical Systems, Inc., and Visiopharm.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global digital pathology market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global digital pathology market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global digital pathology market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global digital pathology market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global digital pathology market.